Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy

[1]  C. Cordon-Cardo,et al.  Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Gafà,et al.  Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north Italy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  O. Nanni,et al.  Role of biological markers in the clinical outcome of colon cancer , 2002, British Journal of Cancer.

[4]  G. Peters,et al.  Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. , 2002, Biochimica et biophysica acta.

[5]  H. McLeod,et al.  Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. , 2002, Oncology reports.

[6]  S. Monfardini,et al.  Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. , 2002, Cancer treatment reviews.

[7]  K. Danenberg,et al.  Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy , 2000, Cancer.

[8]  A. Paradiso,et al.  Colorectal Clinical Experimental Oncology Laboratory and 2 , 2022 .

[9]  A. Livingstone,et al.  Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. , 1999, The cancer journal from Scientific American.

[10]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[11]  H. Lenz,et al.  Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. , 1997, Cancer letters.

[12]  S. Groshen,et al.  Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  H. Lenz,et al.  Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. , 1995, PCR methods and applications.

[14]  K. Abrams,et al.  Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases , 1994, The Lancet.

[15]  S. Meijer,et al.  Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Danenberg,et al.  Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. , 1992, Cancer research.

[17]  W. Meyers,et al.  Effective surgical adjuvant therapy for high-risk rectal carcinoma. , 1991, The New England journal of medicine.

[18]  T. Yamaji,et al.  Carcinogenicity of dextran sulfate sodium in relation to its molecular weight. , 1983, Cancer letters.

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[20]  D.,et al.  Regression Models and Life-Tables , 2022 .